[Federal Register Volume 84, Number 92 (Monday, May 13, 2019)]
[Notices]
[Page 20900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09736]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R38 Review.
    Date: June 21, 2019.
    Time: 10:30 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Sanita Bharti, Ph.D. Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W122 
Bethesda, MD 20892-9750 240-276-5909 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Validation of Cancer Markers (UH2/UH3).
    Date: June 26, 2019.
    Time: 12:00 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W244, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: John P. Cairns, Ph.D. Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W244 
Bethesda, MD 20892-9750 240-276-5415 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03.
    Date: June 28, 2019.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W640, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Saejeong J. Kim, Ph.D. Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W640 
Bethesda, MD 20892-9750 240-276-5179 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UE4/U24 Review.
    Date: July 9, 2019.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NCI Shady Grove, 9609 Medical Center Drive, Room 7W110, 
Rockville, MD 20850 (Telephone Conference Call).
    Contact Person: Robert E. Bird, Ph.D. Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W110 
Bethesda, MD 20892-9750 240-276-6344 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Advancing Cancer Immunotherapy by Mitigating-Immune related 
adverse events.
    Date: July 17, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike 
Rockville, MD 20852.
    Contact Person: Shari W. Campbell, DPM, MSHS Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609 Medical 
Center Drive, Room 7W612 Bethesda, MD 20892-9750 240-276-7381 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-09736 Filed 5-10-19; 8:45 am]
 BILLING CODE 4140-01-P